Neurodegenerative disease treatment strategies
Pro Research Analysisby 
Searched over 200M research papers
Current Drug Treatments and Their Limitations in Neurodegenerative Diseases
Most available drug treatments for neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, only provide symptomatic relief and do not cure or significantly slow disease progression. Disease-modifying therapies are still lacking, and drug delivery to the brain remains a major challenge due to the blood–brain barrier. Innovative drug delivery systems, like nanoliposomes and exosomes, are being explored to improve brain targeting and bioavailability. Intranasal administration is also being investigated as a promising route for delivering drugs directly to the brain, bypassing some of these barriers .
Antioxidant and Neuroprotective Strategies
Oxidative stress and mitochondrial dysfunction are common features in neurodegenerative diseases. Antioxidant therapies, including polyphenols, carotenes, vitamins, and hormones like melatonin, have been tested as adjunctive treatments to restore redox balance and protect neural tissue. These agents show neuroprotective effects in conditions such as Alzheimer’s, Parkinson’s, Huntington’s, and amyotrophic lateral sclerosis, though their clinical efficacy varies .
Stem Cell and Exosome-Based Regenerative Therapies
Stem cell therapies, particularly those using mesenchymal stem cells (MSCs) and neural stem cells (NSCs), are being developed to promote brain regeneration, modulate immune responses, and repair damaged tissues. MSC-derived extracellular vesicles (EVs) and exosomes are highlighted for their ability to promote neurite outgrowth, angiogenesis, and tissue repair, offering a cell-free therapeutic approach. These exosomes carry neuroprotective and anti-inflammatory factors, and their use is being actively researched for various neurodegenerative diseases Palanisamy2023Fayazi2021Deng2025+1 MORE.
Immunotherapeutic Approaches
Immunotherapy is emerging as a promising strategy, especially for diseases like Huntington’s and prion diseases. Both active (vaccines) and passive (monoclonal antibodies) immunotherapies aim to target and neutralize disease-specific proteins, such as mutant huntingtin or misfolded prion proteins. Overcoming the blood–brain barrier and immune tolerance are key challenges, but advances in antibody delivery and targeting are under investigation. These strategies may also be applicable to other neurodegenerative diseases characterized by protein aggregation .
Drug Repurposing and Novel Pharmacological Approaches
Repurposing existing drugs with known safety profiles is a cost-effective and efficient strategy for neurodegenerative disease treatment. Several old drugs are being evaluated for new uses in Alzheimer’s, Parkinson’s, Huntington’s, multiple sclerosis, and amyotrophic lateral sclerosis. This approach leverages established pharmacokinetics and can accelerate the development of new therapies .
Targeting Common Mechanisms: Neuroinflammation, Metabolism, and Genetics
Neuroinflammation, metabolic dysfunction, and genetic factors are shared mechanisms across many neurodegenerative diseases. Targeting these pathways offers opportunities for broad-spectrum therapies. For example, glucagon-like peptide-1 (GLP-1) receptor agonists, originally developed for diabetes, show anti-inflammatory and neuroprotective effects in preclinical models of Alzheimer’s and Parkinson’s, and are being tested in clinical trials for neurodegenerative indications Wareham2022Kopp2022.
Regenerative and Rejuvenation Strategies
Cell-based regenerative medicine, including stem cell therapy, direct lineage reprogramming, and partial reprogramming, is being explored to counteract cellular senescence and promote neuronal regeneration. These “R3” strategies—rejuvenation, regeneration, and replacement—aim to restore lost neuronal function and slow disease progression by addressing the underlying cellular aging processes .
Conclusion
Neurodegenerative disease treatment strategies are rapidly evolving, with a shift from symptomatic management to approaches that target underlying disease mechanisms. Promising avenues include advanced drug delivery systems, antioxidant and neuroprotective agents, stem cell and exosome-based therapies, immunotherapy, drug repurposing, and regenerative medicine. While significant challenges remain, especially in delivering therapies to the brain and achieving disease modification, ongoing research continues to expand the range of potential treatments for these debilitating conditions Passeri2022Morén2022Palanisamy2023+7 MORE.
Sources and full results
Most relevant research papers on this topic